Hengrui Medicine completes third unlocking of 2022 employee stock plan

Jiangsu Hengrui Medicine announced the completion of the unlocking and disposal of shares for the third lock-up period of its 2022 employee stock ownership plan. The plan, initially approved in August and September 2022, saw 12 million shares transferred from the company's buyback account to the employee stock ownership plan account on November 4, 2022, at a price of CNY 4.97 per share.

As of the announcement date, the third lock-up period, which matured on November 7, 2025, involved a total of 2.8303 million shares, representing 0.04% of the company's total share capital. Out of these, 1.6568 million shares were transferred to employee stock ownership plan participants via non-trade transfers, while the remaining 1.1735 million shares were sold through centralized competitive bidding.

The company's 2022 employee stock ownership plan management committee will now proceed with the distribution of assets in accordance with the plan's terms. Jiangsu Hengrui Medicine stated it will continue to monitor the plan's progress and fulfill its information disclosure obligations.